Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China
· Delayed Price · Currency is CNY 11.25
+0.07 (0.63%)
Apr 30, 2026, 3:00 PM CST
SHA:603439 Revenue
Guizhou Sanli Pharmaceutical Co.,Ltd had revenue of 381.73M CNY in the quarter ending March 31, 2026, a decrease of -6.57%. This brings the company's revenue in the last twelve months to 1.68B, down -21.35% year-over-year. In the year 2025, Guizhou Sanli Pharmaceutical Co.,Ltd had annual revenue of 1.70B, down -20.59%.
Revenue (ttm)
1.68B
Revenue Growth
-21.35%
P/S Ratio
2.70
Revenue / Employee
587.65K
Employees
2,852
Market Cap
4.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.70B | -441.54M | -20.59% |
| Dec 31, 2024 | 2.14B | 509.41M | 31.16% |
| Dec 31, 2023 | 1.63B | 433.66M | 36.10% |
| Dec 31, 2022 | 1.20B | 262.35M | 27.94% |
| Dec 31, 2021 | 938.97M | 308.74M | 48.99% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Newland Pharmaceutical | 659.54M |
| Jinling Pharmaceutical Company | 3.20B |
| Shandong Sinobioway Biomedicine | 257.74M |
| Tibet Weixinkang Medicine | 1.16B |
| Zhuhai Rundu Pharmaceutical | 1.19B |
| Jinhe Biotechnology CO., LTD. | 2.75B |
| Shandong Wohua Pharmaceutical | 818.16M |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 543.82M |